Elecsys T3Recalls & reported problems across all models

We found 4 models of Elecsys T3 by Roche Diagnostics GmbH in the FDA's device registry (GUDID). Together they are named in 26 adverse event reports in the FDA's MAUDE database, received between Jul 19, 2018 and Jan 26, 2026 — classified as 26 malfunctions.

The most frequently reported specific device problem is “High Test Results” (16 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event. Widely used products collect more reports, so totals can't be used to compare products or estimate failure rates. Only reports that name a model's exact device identifier are counted. What reports can and can't tell you · How this data works

Most reported Elecsys T3 problems

Elecsys T3 models

4 models, most reported first. Each model has its own page with its reports, recalls and device details.

• Elecsys T3 07027869190

  RADIOIMMUNOASSAY, TOTAL TRIIODOTHYRONINE
  10 reports
• Elecsys T3 09007733190

  RADIOIMMUNOASSAY, TOTAL TRIIODOTHYRONINE
  10 reports
• Elecsys T3 11731360122

  RADIOIMMUNOASSAY, TOTAL TRIIODOTHYRONINE
  4 reports
• Elecsys T3 09007725190

  RADIOIMMUNOASSAY, TOTAL TRIIODOTHYRONINE
  2 reports

Recent Elecsys T3 adverse event reports

The 15 most recent reports across all models, in the reporter's own words as published by the FDA.

• MalfunctionJan 26, 2026Non Reproducible Results

  1. THERE WAS AN ALLEGATION OF QUESTIONABLE ELECSYS T3 RESULTS FOR ONE PATIENT FROM THE COBAS E411 RACK ANALYZER. 2. PATIENT AGE RANGE: ASKU. 3. PATIENT WEIGHT RANGE: ASKU. 4. PATIENT SEX BREAKDOWN: ASKU. 5. PATIENT RACE BREAKDOWN: ASKU. 6. PATIENT ETHNICITY BREAKDOWN: ASKU.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 24183981 ↗
• MalfunctionJan 26, 2026High Test Results

  1. DESCRIBE THE EVENT: THERE WAS AN ALLEGATION OF QUESTIONABLE ELECSYS T3 RESULTS FOR 2 PATIENT SAMPLES TESTED ON COBAS E 801 ANALYTICAL UNITS. 2. PATIENT AGE RANGE: 4-66 YEARS. 3. PATIENT WEIGHT RANGE: ASKU. 4. PATIENT SEX BREAKDOWN: 2-MALE. 5. PATIENT RACE BREAKDOWN: 1-ASKU, 1-ASIAN. 6. PATIENT ETHNICITY BREAKDOWN: 1-ASKU, 1-NON-HISPANIC/LATINO.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 24183968 ↗
• MalfunctionOct 23, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

  1. THERE WAS AN ALLEGATION OF QUESTIONABLE ELECSYS T3 RESULTS FOR ONE PATIENT FROM THE COBAS 6000 E601 MODULE. 2. PATIENT AGE RANGE: 53 YEARS. 3. PATIENT WEIGHT RANGE: ASKU. 4. PATIENT SEX BREAKDOWN: MALE. 5. PATIENT RACE BREAKDOWN: ASKU. 6. PATIENT ETHNICITY BREAKDOWN: ASKU.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 23369194 ↗
• MalfunctionJul 24, 2025High Test Results; High Test Results

  1. DESCRIBE THE EVENT: THE INITIAL REPORTER QUESTIONED THE RESULTS FOR 1 PATIENT TESTED WITH ELECSYS T3 ON A COBAS E 801 ANALYTICAL UNIT. 2. PATIENT AGE RANGE: ASKU. 3. PATIENT WEIGHT RANGE: ASKU. 4. PATIENT SEX BREAKDOWN: ASKU. 5. PATIENT RACE BREAKDOWN: ASKU. 6. PATIENT ETHNICITY BREAKDOWN: ASKU.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 22587467 ↗
• MalfunctionApr 29, 2025Incorrect Measurement; Chemical Problem; Incorrect Measurement; Chemical Problem

  1. THERE WAS AN ALLEGATION OF QUESTIONABLE ELECSYS T3 RESULTS FOR APPROXIMATELY 60 SAMPLES FROM THE COBAS E 801 ANALYTICAL UNIT. 2. PATIENT AGE RANGE: ASKU 3. PATIENT WEIGHT RANGE: ASKU 4. PATIENT SEX BREAKDOWN: ASKU 5. PATIENT RACE BREAKDOWN: ASKU 6. PATIENT ETHNICITY BREAKDOWN: ASKU.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 21925105 ↗
• MalfunctionFeb 4, 2025High Test Results; High Test Results

  THE INITIAL REPORTER QUESTIONED THYROID RESULTS FOR 1 PATIENT ON A COBAS E 801 ANALYTICAL UNIT COMPARED TO A COMPETITOR METHOD. OF THE DATA PROVIDED, THE RESULTS FOR FT3, T4, T3, ANTI-TG AND ANTI-TPO WERE DISCREPANT. REFER TO THE ATTACHED DATA FOR THE PATIENT RESULTS. THIS MEDWATCH WILL COVER T3. REFER TO MEDWATCH WITH A1 PATIENT IDENTIFIER (B)(6) FOR INFORMATION ON THE T4 RESULTS, MEDWATCH WITH A1 PATIENT IDENTIFIER (B)(6) FOR INFORMATION ON THE FT3 RESULTS, MEDWATCH WITH A1 PATIENT IDENTIFIER (B)(6) FOR INFORMATION ON THE ANTI-TG RESULTS AND MEDWATCH WITH A1 PATIENT IDENTIFIER (B)(6) FOR INFORMATION ON THE ANTI-TPO RESULTS.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 21306968 ↗
• MalfunctionJan 29, 2025Low Test Results; Low Test Results

  1. DESCRIBE THE EVENT: THERE WAS AN ALLEGATION OF QUESTIONABLE ELECSYS T3 RESULTS FOR 1 PATIENT ON A COBAS 8000 CORE UNIT. 2. PATIENT AGE RANGE: ASKU. 3. PATIENT WEIGHT RANGE: ASKU. 4. PATIENT SEX BREAKDOWN: ASKU. 5. PATIENT RACE BREAKDOWN: ASKU. 6. PATIENT ETHNICITY BREAKDOWN: ASKU.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 21266820 ↗
• MalfunctionNov 4, 2024High Test Results; High Test Results

  THE INITIAL REPORTER RECEIVED QUESTIONABLE ELECSYS T4 (T4), ELECSYS FT3 III VER.2, AND ELECSYS T3 (T3) ASSAY RESULTS FROM ONE PATIENT SAMPLE TESTED ON THE COBAS E 801 ANALYTICAL UNIT. THIS MEDWATCH IS FOR THE ELECSYS T3 (T3) ASSAY. PLEASE REFER TO THE MEDWATCH WITH: A1. PATIENT IDENTIFIER (B)(6) FOR THE ELECSYS T4 (T4) ASSAY. A1. PATIENT IDENTIFIER (B)(6) FOR THE ELECSYS FT3 III VER.2 ASSAY. THE QUESTIONABLE RESULTS WERE NOT REPORTED OUTSIDE THE LABORATORY AS THEY DID NOT MATCH THE PATIENT'S CLINICAL DIAGNOSIS. PLEASE REFER TO THE ATTACHMENT (B)(6) FOR THE TABLE CONTAINING THE HIGHLIGHTED QUESTIONABLE RESULTS.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 20603346 ↗
• MalfunctionDec 20, 2023High Test Results; Chemical Problem; High Test Results; Chemical Problem

  THERE WAS AN ALLEGATION OF QUESTIONABLE ELECSYS T3, ELECSYS T4 ASSAY, AND ELECSYS TSH ASSAY RESULTS FOR 6 PATIENT SAMPLES ON A COBAS E 801 ANALYTICAL UNIT COMPARED TO TREE COMPETITOR ANALYZERS. THIS MEDWATCH WILL COVER T3. REFER TO MEDWATCH WITH A1 PATIENT IDENTIFIER (B)(6) FOR INFORMATION ON THE T4 RESULTS AND MEDWATCH WITH A1 PATIENT IDENTIFIER (B)(6) FOR INFORMATION ON THE TSH RESULTS. REFER TO THE ATTACHMENT TO THE MEDWATCH FOR ALL PATIENT DATA. THE UNITS OF MEASUREMENT FOR THE TSH RESULTS AND FOR THE COMPETITOR ANALYZER RESULTS WERE NOT PROVIDED. THE REFERENCE RANGES FOR ALL ASSAYS WERE NOT PROVIDED.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 18365973 ↗
• MalfunctionDec 15, 2023False Positive Result; False Positive Result

  THERE WAS AN ALLEGATION OF QUESTIONABLE ELECSYS T3, ELECSYS T4 ASSAY, ELECSYS FT3 III, ELECSYS FT4 III ASSAY, ELECSYS ANTI-TPO, AND ELECSYS ANTI-TG RESULTS FOR 1 PATIENT SAMPLE ON A COBAS E 801 MODULE COMPARED TO AN ABBOTT ANALYZER. THIS MEDWATCH WILL COVER T3. REFER TO MEDWATCH WITH A1 PATIENT IDENTIFIER (B)(6) FOR INFORMATION ON THE FT3 III RESULTS, MEDWATCH WITH A1 PATIENT IDENTIFIER (B)(6) FOR INFORMATION ON THE T4 RESULTS, MEDWATCH WITH A1 PATIENT IDENTIFIER (B)(6) FOR INFORMATION ON THE FT4 III RESULTS, MEDWATCH WITH A1 PATIENT IDENTIFIER (B)(6) FOR INFORMATION ON THE ANTI-TPO RESULTS, AND MEDWATCH WITH A1 PATIENT IDENTIFIER (B)(6) FOR INFORMATION ON THE ANTI-TG RESULTS. REFER TO THE ATTACHMENT TO THE MEDWATCH FOR ALL PATIENT DATA. NO QUESTIONABLE RESULTS WERE REPORTED OUTSIDE OF THE LABORATORY.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 18335905 ↗
• MalfunctionNov 29, 2023Incorrect Measurement; High Test Results; Incorrect Measurement; High Test Results

  THE INITIAL REPORTER STATED THEY RECEIVED QUESTIONABLE RESULTS FOR ONE PATIENT SAMPLE TESTED WITH ELECSYS T3 AND ELECSYS T4 ON A COBAS E 801 ANALYTICAL UNIT. THE CUSTOMER STATES THAT THE T3 AND T4 VALUES WERE ABNORMALLY ELEVATED, BUT TSH WAS NORMAL. THE RESULTS WERE NOT IN LINE WITH THE PATIENT'S CLINICAL MANIFESTATIONS. NO QUESTIONABLE RESULTS WERE REPORTED OUTSIDE OF THE LABORATORY. THIS MEDWATCH WILL APPLY TO THE T3 ASSAY. PLEASE REFER TO THE MEDWATCH WITH A1. PATIENT IDENTIFIER (B)(6) FOR INFORMATION RELATED TO THE T4 ASSAY. REFER TO THE ATTACHMENT FOR THE PATIENT'S RESULTS. THE T3 AND T4 VALUES FROM THE (B)(6) 2023 SAMPLE ARE QUESTIONED. THE SAMPLE WAS REPEATED AFTER THE PATIENT SAMPLE WAS TREATED WITH THE STREPTAVIDIN-COATED MICROPARTICLE PORTION OF THE T3 AND T4 REAGENTS. FOR THIS TREATMENT, THE SAMPLE AND MICROPARTICLE PORTION OF THE REAGENTS WERE INCUBATED AT 37 DEGREES CELCIUS FOR 30 MINUTES, THE SUPERNATANT WAS THEN CENTRIFUGED AND TESTED.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 18232764 ↗
• MalfunctionMay 18, 2023Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

  THERE WAS AN ALLEGATION OF QUESTIONABLE ELECSYS T3 RESULTS FOR 1 PATIENT SAMPLE ON A COBAS E 801 ANALYTICAL UNIT. THIS MEDWATCH WILL COVER T3. REFER TO MEDWATCH WITH A1 PATIENT IDENTIFIER (B)(6) FOR INFORMATION ON THE FT3 RESULTS, MEDWATCH WITH A1 PATIENT IDENTIFIER (B)(6) FOR INFORMATION ON THE FT4 RESULTS, AND MEDWATCH WITH A1 PATIENT IDENTIFIER (B)(6) FOR INFORMATION ON THE TSH RESULTS. REFER TO THE ATTACHMENT TO THE MEDWATCH FOR ALL PATIENT DATA. THE INITIAL RESULTS WERE REPORTED OUTSIDE OF THE LABORATORY. THE DOCTOR QUESTIONED THE RESULTS AS THEY DID NOT MATCH THE PATIENT'S CLINICAL PICTURE. THE ANALYZER SERIAL NUMBER IS (B)(6).

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 16955691 ↗
• MalfunctionMar 28, 2023High Test Results; High Test Results

  THE INITIAL REPORTER RECEIVED QUESTIONABLE ELECSYS T3 AND ELECSYS T4 ASSAY RESULTS FROM TWO PATIENT SAMPLES TESTED ON THE COBAS E 801 MODULE WITH UNKNOWN SERIAL NUMBER. THE REPORTER STATED THAT THE RESULTS THEY OBTAINED FROM THE MODULE WERE SIGNIFICANTLY HIGHER THAN THOSE FROM AN ABBOTT SYSTEM. THE INITIAL RESULTS WERE NOT REPORTED OUTSIDE OF THE LABORATORY. THIS MEDWATCH IS FOR THE T3 ASSAY. PLEASE REFER TO MEDWATCH WITH PATIENT IDENTIFIER: (B)(6) FOR THE T4 ASSAY. PLEASE REFER TO THE ATTACHMENT IN THE MEDWATCH FOR THE TABLE CONTAINING THE QUESTIONABLE RESULTS. THE REPORTER STATED THAT THE RESULTS FROM EACH METHOD WERE NOT PRESENTING THE SAME CLINICAL INTERPRETATION.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 16631539 ↗
• MalfunctionNov 4, 2022Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

  THE INITIAL REPORTER STATED THEY RECEIVED QUESTIONABLE THYROID ASSAY RESULTS FOR TWO SAMPLES COLLECTED FROM THE SAME PATIENT TESTED ON A COBAS 8000 E 801 MODULE. RESULTS FROM THE FOLLOWING ASSAYS WERE AFFECTED: ELECSYS T3, THE ELECSYS T4 ASSAY, ELECSYS FT3 III, THE ELECSYS FT4 ASSAY, ROCHE DIAGNOSTICS ELECSYS ANTI-TG, AND ROCHE DIAGNOSTICS COBAS ELECSYS ANTI-TPO. THE THYROID RESULTS WERE NOT CONSISTENT WITH THE PATIENT'S CLINICAL SITUATION. ALL RESULTS WERE REPORTED OUTSIDE OF THE LABORATORY TO THE DOCTOR AND PATIENT. THIS MEDWATCH WILL APPLY TO THE T3 ASSAY. PLEASE REFER TO THE MEDWATCH WITH PATIENT IDENTIFIER (B)(6) FOR INFORMATION RELATED TO THE T4 ASSAY. PLEASE REFER TO THE MEDWATCH WITH PATIENT IDENTIFIER (B)(6) FOR INFORMATION RELATED TO THE FT3 ASSAY. PLEASE REFER TO THE MEDWATCH WITH PATIENT IDENTIFIER (B)(6) FOR INFORMATION RELATED TO THE FT4 ASSAY. PLEASE REFER TO THE MEDWATCH WITH PATIENT IDENTIFIER (B)(6) FOR INFORMATION RELATED TO THE ANTI-TG ASSAY. PLEASE REFER TO THE MEDWATCH WITH PATIENT IDENTIFIER (B)(6) FOR INFORMATION RELATED TO THE ANTI-TPO ASSAY. REFER TO THE ATTACHMENT FOR ALL PATIENT DATA. THE SAMPLE FROM (B)(6) 2022 WAS REPEATED ON (B)(6) 2022. AN EXPERIMENT

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 15727197 ↗
• MalfunctionAug 15, 2022High Test Results; High Test Results

  THE INITIAL REPORTER COMPLAINED OF DISCREPANT HIGH RESULTS FOR 1 PATIENT SAMPLE TESTED FOR ELECSYS T3 (T3), ELECSYS FT3 III (FT3 III) AND ELECSYS T4 (T4) ON A COBAS 8000 CORE UNIT COMPARED TO THE SIEMENS METHOD. THIS MEDWATCH WILL COVER T3. REFER TO MEDWATCH WITH A1 PATIENT IDENTIFIER (B)(6) FOR INFORMATION ON THE FT3 III RESULTS AND MEDWATCH WITH A1 PATIENT IDENTIFIER (B)(6) FOR INFORMATION ON THE T4 RESULTS. THE T3 RESULT FROM THE ROCHE METHOD WAS 3.56 NG/ML. THE RESULT FROM THE SIEMENS METHOD WAS 1.13 NG/ML. THE FT3 III RESULT FROM THE ROCHE METHOD WAS 7.26 PG/ML. THE RESULT FROM THE SIEMENS METHOD WAS 3.22 PG/ML. THE T4 RESULT FROM THE ROCHE METHOD WAS 24.9 UG/DL. THE RESULT FROM THE SIEMENS METHOD WAS 7.78 UG/DL. THE ROCHE RESULTS WERE REPORTED OUTSIDE OF THE LABORATORY WHERE THEY DID NOT CORRESPOND TO THE PATIENT¿S CLINICAL CONDITION. THE SIEMENS RESULTS WERE BELIEVED TO BE "NORMAL." THE COBAS 8000 CORE UNIT SERIAL NUMBER WAS (B)(4).

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 15224962 ↗

Other Roche Diagnostics GmbH products

• cobas e 411 Immunoassay Analyzer2 models · 1,218 reports
• cobas e 801 Immunoassay analyzer3 models · 713 reports · 1 recall
• CoaguChek XS PT strips2 models · 632 reports
• CoaguChek XS Patient Self Testing Care Kit2 models · 346 reports
• Elecsys FT3 III4 models · 283 reports
• Elecsys Estradiol III2 models · 162 reports
• Elecsys TSH4 models · 155 reports
• Sodium electrode3 models · 150 reports